BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12387014)

  • 1. [Structure and action mechanism of sulfonylurea].
    Tasaka Y
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():333-8. PubMed ID: 12387014
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulfonylurea-mediated stimulation of insulin exocytosis via an ATP-sensitive K+ channel-independent action.
    Renström E; Barg S; Thévenod F; Rorsman P
    Diabetes; 2002 Feb; 51 Suppl 1():S33-6. PubMed ID: 11815455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of sulphonylureas: role of K(ATP) channels.
    Howes LG
    Diabetes Obes Metab; 2000 Apr; 2(2):67-73. PubMed ID: 11220526
    [No Abstract]   [Full Text] [Related]  

  • 4. ATP-sensitive K+ channels and insulin secretion: their role in health and disease.
    Ashcroft FM; Gribble FM
    Diabetologia; 1999 Aug; 42(8):903-19. PubMed ID: 10491749
    [No Abstract]   [Full Text] [Related]  

  • 5. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells.
    Sato Y; Anello M; Henquin JC
    Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sulfonylurea drugs for type 2 diabetes].
    Toyota T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():339-45. PubMed ID: 12387015
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanisms of action of peroral antidiabetics. Sulfonylurea preparations block the ATP-dependent potassium channels].
    Larsson O; Kindmark H; Bränström R; Berggren PO
    Lakartidningen; 1997 Nov; 94(48):4473-7. PubMed ID: 9424548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Structures and mechanisms for non SU insulin secretagogues].
    Kikuchi M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():362-70. PubMed ID: 12387019
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of pancreatic B-cell dysfunction and glucose toxicity in non-insulin-dependent diabetes.
    Flatt PR; Barnett CR; Swanston-Flatt SK
    Biochem Soc Trans; 1994 Feb; 22(1):18-23. PubMed ID: 8206220
    [No Abstract]   [Full Text] [Related]  

  • 10. [The sulfonylurea receptor].
    Inagaki N; Gonoi T; Seino S
    Seikagaku; 1997 Sep; 69(9):1067-80. PubMed ID: 9364874
    [No Abstract]   [Full Text] [Related]  

  • 11. [Molecular mechanisms of insulin secretion].
    Minami K; Shibasaki T; Miki T; Seino S
    Seikagaku; 2003 Oct; 75(10):1312-23. PubMed ID: 14635523
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of insulin secretion and its modulation by sulfonylureas.
    Panten U
    Contrib Nephrol; 1989; 73():16-21; discussion 22-3. PubMed ID: 2689091
    [No Abstract]   [Full Text] [Related]  

  • 13. [Primary and secondary failure of sulphonylureas].
    Kanno H; Sakura H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():719-23. PubMed ID: 12430308
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological approach to understanding the control of insulin secretion in human islets.
    Henquin JC; Dufrane D; Gmyr V; Kerr-Conte J; Nenquin M
    Diabetes Obes Metab; 2017 Aug; 19(8):1061-1070. PubMed ID: 28116849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of sulphonylureas with special reference to the extrapancreatic effect: an overview.
    Beck-Nielsen H; Hother-Nielsen O; Pedersen O
    Diabet Med; 1988 Oct; 5(7):613-20. PubMed ID: 2975544
    [No Abstract]   [Full Text] [Related]  

  • 16. Sulfonylurea receptors and mechanism of sulfonylurea action.
    Panten U; Schwanstecher M; Schwanstecher C
    Exp Clin Endocrinol Diabetes; 1996; 104(1):1-9. PubMed ID: 8750563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ATP-sensitive potassium channels and substances affecting them].
    Pospísilová Y
    Vnitr Lek; 1998 Jul; 44(7):435-8. PubMed ID: 9748883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular mechanisms of insulin secretion].
    Bataille D
    Diabetes Metab; 2002 Dec; 28(6 Suppl):4S7-13. PubMed ID: 12703060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin release form isolated, human islets after acute or prolonged exposure to glimepiride.
    Del Guerra S; Parentini C; Bracci C; Lupi R; Marselli L; Aragona M; Navalesi R; Marchetti P
    Acta Diabetol; 2000; 37(3):139-41. PubMed ID: 11277315
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacology of glimepiride].
    Satoh Y
    Nihon Rinsho; 1997 Nov; 55 Suppl():147-51. PubMed ID: 9434459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.